Follow
Miguel Ángel Santos Santos
Miguel Ángel Santos Santos
Neurologist, specialist in behavioral neurology
Verified email at santpau.cat
Title
Cited by
Cited by
Year
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
R Ossenkoppele, DR Schonhaut, M Schöll, SN Lockhart, N Ayakta, ...
Brain 139 (5), 1551-1567, 2016
7332016
Typical and atypical pathology in primary progressive aphasia variants
EG Spinelli, ML Mandelli, ZA Miller, MA Santos‐Santos, SM Wilson, ...
Annals of neurology 81 (3), 430-443, 2017
2562017
Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia
MA Santos-Santos, GD Rabinovici, L Iaccarino, N Ayakta, G Tammewar, ...
JAMA neurology 75 (3), 342-352, 2018
162*2018
Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy
R Ossenkoppele, DR Schonhaut, SL Baker, JP O'neil, M Janabi, ...
Annals of neurology 77 (2), 338-342, 2015
1382015
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
D Bergeron, ML Gorno‐Tempini, GD Rabinovici, MA Santos‐Santos, ...
Annals of neurology 84 (5), 729-740, 2018
1022018
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
D Bergeron, ML Gorno‐Tempini, GD Rabinovici, MA Santos‐Santos, ...
Annals of neurology 84 (5), 729-740, 2018
1022018
Features of patients with nonfluent/agrammatic primary progressive aphasia with underlying progressive supranuclear palsy pathology or corticobasal degeneration
MA Santos-Santos, ML Mandelli, RJ Binney, J Ogar, SM Wilson, ...
JAMA neurology 73 (6), 733-742, 2016
972016
Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia
ML Mandelli, E Vilaplana, JA Brown, HI Hubbard, RJ Binney, S Attygalle, ...
Brain 139 (10), 2778-2791, 2016
962016
Rates of amyloid imaging positivity in patients with primary progressive aphasia
MA Santos-Santos, GD Rabinovici, L Iaccarino, N Ayakta, G Tammewar, ...
JAMA neurology 75 (3), 342-352, 2018
742018
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ ACE project
S Moreno‐Grau, I de Rojas, I Hernández, I Quintela, L Montrreal, ...
Alzheimer's & Dementia 15 (10), 1333-1347, 2019
632019
Reading words and other people: a comparison of exception word, familiar face and affect processing in the left and right temporal variants of primary progressive aphasia
RJ Binney, ML Henry, M Babiak, PS Pressman, MA Santos-Santos, ...
Cortex 82, 147-163, 2016
632016
Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA
ML Mandelli, P Vitali, M Santos, M Henry, K Gola, L Rosenberg, ...
Cortex 74, 149-157, 2016
452016
Visuospatial functioning in the primary progressive aphasias
CL Watson, K Possin, IE Allen, HI Hubbard, M Meyer, AE Welch, ...
Journal of the International Neuropsychological Society 24 (3), 259-268, 2018
432018
Prevalence of Mathematical and Visuospatial Learning Disabilities in Patients With Posterior Cortical Atrophy
ZA Miller, L Rosenberg, MA Santos-Santos, M Stephens, IE Allen, ...
JAMA neurology 75 (6), 728-737, 2018
402018
Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
D Sánchez, M Castilla-Marti, O Rodríguez-Gómez, S Valero, A Piferrer, ...
Scientific reports 8 (1), 1-10, 2018
392018
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
D Alcolea, J Clarimón, M Carmona-Iragui, I Illán-Gala, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019
322019
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
C Delaby, D Alcolea, M Carmona-Iragui, I Illán-Gala, ...
Scientific Reports 10 (1), 1-8, 2020
292020
Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundacio ACE healthy brain initiative (FACEHBI)
I de Rojas, J Romero, O Rodriguez-Gomez, P Pesini, A Sanabria, ...
Alzheimer's research & therapy 10 (1), 1-12, 2018
282018
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy …
S Moreno–Grau, O Rodríguez‐Gómez, A Sanabria, A Pérez‐Cordón, ...
Alzheimer's & Dementia 14 (5), 634-643, 2018
222018
Visual impairment in aging and cognitive decline: experience in a Memory Clinic
M Marquié, M Castilla-Martí, S Valero, J Martínez, D Sánchez, ...
Scientific reports 9 (1), 1-10, 2019
212019
The system can't perform the operation now. Try again later.
Articles 1–20